Loading...
Loading...
Application UK00915218671 · Registered
| Application Number | UK00915218671 |
| Status | Registered |
| Owner | INSUD PHARMA, S.L. |
| Filed | 2016-03-15 |
| Registered | 2016-08-26 |
| Renewal Due | 2036-03-15 |
| Type | Individual |
| Feature | Word |
| Attorney | See claim section below |
Yes. XIROMED is currently a registered UK trademark, with renewal due on 2036-03-15. It is protected under UK intellectual property law and can be enforced against infringing uses.
The specification below is taken directly from the filed record at the UK IPO for each Nice class this trademark is registered in.
Pharmaceuticals for use in the treatment of diseases and disorders of the digestive system, gynaecological diseases and disorders, hormonal diseases and disorders, blood diseases, cancer, cardiovascular diseases, vascular diseases, gastrointestinal diseases, genitourinary diseases, immunological diseases, infectious diseases, inflammatory diseases, metabolic diseases and disorders, neurological diseases, psychiatric diseases, treatment of the central nervous system, the musculoskeletal system, the respiratory system, the circulatory system, viral diseases, glaucoma, dental and oral diseases, headaches, migraines, obesity, liver treatments, cholesterol, high blood pressure and rheumatic treatments; Veterinary preparations for the treatment of diseases and disorders of the digestive system, gynaecological diseases and disorders, blood disorders, cancer, cardiovascular diseases, vascular diseases, gastrointestinal diseases, genitourinary diseases, immunological diseases, infectious diseases, inflammatory diseases, metabolic diseases and disorders, neurological diseases, the central nervous system, the musculoskeletal system, the respiratory system, the circulatory system, viral diseases, glaucoma, dental and oral diseases, headaches, migraines, obesity, liver treatments, cholesterol, high blood pressure and rheumatic treatments.
Sales promotion for others; Business management support; Business management consultancy; Marketing studies; Presentation of goods via all kinds of communications media, for retail purposes; Commercial administration of the licensing of the goods and services of others; Organisation of exhibitions, trade fairs or congresses for commercial or advertising purposes, all the aforesaid relating to pharmaceutical businesses, and for pharmaceuticals.
Distribution, transport, packaging and storage of pharmaceuticals.
Chemical, biological and pharmaceutical research services; development of pharmaceutical preparations; Clinical studies related to pharmaceutical products; Evaluation and inspection of pharmaceuticals.
'XIROMED' is a registered trademark on the UK IPO register, owned by INSUD PHARMA, S.L.. The application (UK00915218671) was filed on 15 March 2016 and registered on 26 August 2016. The registration is set to expire on 15 March 2036.
This mark is recorded under multiple classes: Class 5 (pharmaceuticals & medical preparations); Class 35 (advertising, business management & retail services); Class 39 (transport, packaging & storage services); Class 42 (scientific, IT & design services).
The trademark is represented by ARS PRIVILEGIUM, S.L..
UK trademark UK00915218671 for the mark 'XIROMED' in Class 5, 35, 39, 42 is recorded on the UK IPO register as owned by INSUD PHARMA, S.L.. This covers one specific UK trademark record only — the same brand name may be owned by different parties in other classes, other countries, or as separate registrations.
Yes — the UK IPO records UK trademark UK00915218671 for the mark 'XIROMED' as registered.
UK trademark UK00915218671 for the mark 'XIROMED' is recorded in Class 5 (pharmaceuticals & medical preparations); Class 35 (advertising, business management & retail services); Class 39 (transport, packaging & storage services); Class 42 (scientific, IT & design services). The filed specification reads: Class 5: Pharmaceuticals for use in the treatment of diseases and disorders of the digestive system, gynaecological diseases and disorders, hormonal diseases and disorders, blood diseases, cancer, cardiovascular diseases, vascular diseases, gastrointestinal diseases, genitourinary diseases, immunological diseases, i…
UK trademark UK00915218671 for the mark 'XIROMED' was filed at the UK IPO on 15 March 2016 and registered on 26 August 2016.
UK trademark UK00915218671 for the mark 'XIROMED' is currently recorded as valid until 15 March 2036, at which point it will need to be renewed with the UK IPO to remain in force.
ARS PRIVILEGIUM, S.L. is listed as the attorney / representative of record for UK trademark UK00915218671 for the mark 'XIROMED' on the UK IPO register.
This trademark has an attorney of record listed on the UK register. The firm has not yet claimed its listing on Trademark Dashboard.
Trademarks matching "XIROMED" have been found on the following foreign registers. Exact matches appear first; where the name also appears inside longer filings, those are listed below as similar marks. A “Same applicant” badge appears next to a mark when the applicant name aligns with the source filing.
| Mark | Ref | Status | Filed |
|---|---|---|---|
| XIROMEDSame applicant | 87091052 | 700 | 2016-07-01 |
| XIROMEDSame applicant | 86949502 | 700 | 2016-03-23 |
Similar names
| Mark | Ref | Status | Filed |
|---|---|---|---|
| XIROM UN | 97641781 | 700 | 2022-10-21 |
| XIROMUN | 97584354 | 700 | 2022-09-09 |
| Mark | Ref | Status | Filed |
|---|---|---|---|
| XIROMEDSame applicant | 2263588 | protected | 2022-04-14 |
UK trademark data is supplied by the Intellectual Property Office under the Open Government Licence v3.0.
US trademark data is supplied by the United States Patent and Trademark Office. Works of the US federal government are in the public domain under 17 U.S.C. §105.
Australian trademark data is supplied by IP Australia (via IPGOD / IP RAPID) under the Creative Commons Attribution 4.0 International licence.
The “About This Trademark” summary and FAQ above are AI-generated from the register data shown on this page. They are factual summaries only — always verify details against the official register before making legal decisions.